CD274 and cancer: Immune checkpoint blockade (e.g., anti-PD1/PD-L1), adoptive cell transfer (e.g., CAR T), cancer vaccines (e.g., Sipuleucel-T) and immunostimulatory cytokines (e.g., IL-2) are the principal immunotherapeutic tools [16,17,18].